Asmacure Ltée
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2002-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.asmacure.com
Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD)
- First Posted Date
- 2013-05-16
- Last Posted Date
- 2014-12-16
- Lead Sponsor
- Asmacure Ltée
- Target Recruit Count
- 14
- Registration Number
- NCT01855230
- Locations
- 🇨🇦
Institut universitaire de cardiologie et de pneumologie de Québec, Quebec, Canada
Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- Asmacure Ltée
- Target Recruit Count
- 55
- Registration Number
- NCT01793298
- Locations
- 🇨🇦
Institut universitaire de cardiologie et de pneumologie de Québec, Québec, Quebec, Canada
🇨🇦PharmaNet, Québec, Quebec, Canada
Safety, Tolerability and Clinical Activity of ASM-024 in Stable Moderate Asthma
- First Posted Date
- 2010-08-30
- Last Posted Date
- 2012-03-15
- Lead Sponsor
- Asmacure Ltée
- Target Recruit Count
- 20
- Registration Number
- NCT01190826
- Locations
- 🇨🇦
Anapharm, Montreal, Quebec, Canada
🇨🇦McMaster University, Hamilton, Ontario, Canada
🇨🇦Centre de Recherche Institut universitaire de cardiologie et de pneumologie de Québec, Quebec, Canada
Safety, Tolerability and Clinical Activity of ASM-024 in Subjects With Mild Allergic Asthma
- First Posted Date
- 2010-03-25
- Last Posted Date
- 2012-01-26
- Lead Sponsor
- Asmacure Ltée
- Target Recruit Count
- 24
- Registration Number
- NCT01092403
- Locations
- 🇨🇦
University of Saskatechewan, Saskatoon, Saskatchewan, Canada
🇨🇦Mc Master University Health Sciences Center, Hamilton, Quebec, Canada
🇨🇦Centre de Recherche - Institut universitaire de cardiologie et de pneumologie de Québec, Québec, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath